Introducing a novel approach to enhance checkpoint inhibitor therapy for cancer, promising improved treatment outcomes and efficacy in clinical...

Researchers have developed a new nanomedicine therapy that delivers anticancer drugs to  lung cancer cells and enhances the immune system’s ability...

Researchers at the University of Turku in Finland have found a new function for an existing protein. They discovered that TIMP-1, a protein...

Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung...

Researchers found that the protein TIMP-1 plays a crucial role in the immune system's defense system.

Periods of fasting reprogram the immune system’s natural killer cells to better fight cancer, according to a new study in mice from researchers at...

Because not all cancer patients respond to a leading type of cancer immunotherapy drug, known as an immune checkpoint inhibitor, scientists explored...

Researchers at the University of Turku in Finland discovered that TIMP-1, a protein traditionally known for protecting cells and tissues, also plays...

Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung...

A paper published in May in the American Gastroenterological Association journalCellular and Molecular Gastroenterology and Hepatology focusses on...